Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Stem Cell Therapy was estimated at US$379.3 Million in 2023 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 16.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
How Is Stem Cell Therapy Integrated Across Healthcare?
In orthopedics, stem cell therapy is used to treat joint injuries, cartilage damage, and tendon repair by promoting tissue regeneration, reducing pain, and improving mobility. In neurology, stem cells offer potential treatments for conditions like Parkinson's disease, spinal cord injuries, and stroke recovery by replacing damaged neurons and supporting neural repair. In cardiology, stem cell therapy targets heart tissue regeneration following heart attacks, aiming to improve cardiac function and reduce complications. Additionally, autoimmune diseases like multiple sclerosis and systemic lupus erythematosus are treated with stem cell transplants that reset the immune system and provide long-term remission.
What Factors Are Driving the Growth in the Stem Cell Therapy Market?
The growth in the Stem Cell Therapy market is driven by several factors, including increasing demand for regenerative treatments that address conditions with limited curative options, such as neurodegenerative diseases, heart failure, and immune disorders. Advancements in stem cell research, clinical protocols, and delivery methods have improved the safety, efficacy, and accessibility of these therapies, supporting wider adoption across medical fields.
The focus on personalized medicine and tailored treatments has further fueled demand, as stem cell therapy enables individualized care based on patient-specific conditions and genetic profiles. Additionally, growing regulatory approvals, increased clinical trial success rates, and rising investments in biotechnology and regenerative medicine have contributed to market growth, accelerating the development and commercialization of stem cell therapies.
Scope of the Study
The report analyzes the Stem Cell Therapy market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below.
Segments
- Type (Allogeneic, Autologous); Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-Derived MSCs, Placental / Umbilical Cord-Derived MSCs, Other Cell Sources); Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, Other Applications)
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Allogeneic Stem Cell Therapy segment, which is expected to reach US$1 Billion by 2030 with a CAGR of a 16.7%. The Autologous Stem Cell Therapy segment is also set to grow at 10% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $104.4 Million in 2023, and China, forecasted to grow at an impressive 15.5% CAGR to reach $165.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Stem Cell Therapy Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stem Cell Therapy Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Stem Cell Therapy Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Global Stem Cell Therapy Market such as Advanced Cell Technology, Anterogen, Ltd., Biotime, Osiris Therapeutics, Cynata, Cytori Therapeutics and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 12 companies featured in this Global Stem Cell Therapy Market report include:
- Advanced Cell Technology
- Anterogen, Ltd.
- Biotime, Osiris Therapeutics
- Cynata
- Cytori Therapeutics
- HolostemTerapieAvanzateS.r.l.
- Human Longevity
- JCR Pharmaceuticals
- Medipost
- Mesoblastand AlloSource
- NuVasive
- Osiris Therapeutics, Inc.
- Pharmicell
- Promethera Biosciences
- RTI Surgical
- Stemcell Technologies
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 78 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $379.3 Million |
| Forecasted Market Value (USD) by 2030 | $1100 Million |
| Compound Annual Growth Rate | 16.4% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Stem Cell Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Prevalence of Chronic Diseases Drives Demand for Stem Cell Therapy
- Increasing Focus on Regenerative Medicine Spurs Growth in Stem Cell Therapy
- Advancements in Cell-Based Immunotherapies Propel Market Expansion
- Rising Adoption in Neurological Disorders Expands Addressable Market
- Growing Use in Hematological Disorders Strengthens Business Case
- Expansion of Cardiovascular Applications Spurs Demand for Stem Cell Therapy
- Emergence of Off-the-Shelf Allogeneic Therapies Enhances Adoption
- Growing Focus on Rare Disease Treatment Expands Market Potential
- Rising Approvals for Clinical Trials Accelerates Demand for Stem Cell Therapy
- Advancements in Gene-Edited Stem Cells Propel Therapeutic Opportunities
- Rising Focus on Age-Related Degenerative Conditions Fuels Demand
- Growing Interest in Autologous Therapies Expands Adoption
- Emergence of Combination Therapies Strengthens Stem Cell Market
FOCUS ON SELECT PLAYERS
- Advanced Cell Technology
- Anterogen, Ltd.
- Biotime, Osiris Therapeutics
- Cynata
- Cytori Therapeutics
- HolostemTerapieAvanzateS.r.l.
- Human Longevity
- JCR Pharmaceuticals
- Medipost
- Mesoblastand AlloSource
- NuVasive
- Osiris Therapeutics, Inc.
- Pharmicell
- Promethera Biosciences
- RTI Surgical
- Stemcell Technologies
For more information about this report visit https://www.researchandmarkets.com/r/31b2fi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
